Fiji vs Ghana: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Ghana
100.0%
in 2024
Fiji rank
1st
Ghana rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Ghana
How they compare
Fiji currently reports 100.0% against 100.0% in Ghana, a difference of 0.0%.
The two have swapped places 7 times across 15 shared years of data; in 2010 it was Fiji ahead.
Fiji ranks 1st and Ghana ranks 1st of 180 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.1% | 68.2% | 20.1% | Ghana |
| 2020s | 81.8% | 98.6% | 16.8% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Ghana?
- Fiji, at 100.0% against 100.0% in Ghana as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Ghana?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Ghana?
- 15 years are reported by both, from 2010 to 2024.
- How do Fiji and Ghana rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Ghana ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.